TITLE

Young children remain primary victims of malaria

PUB. DATE
October 2008
SOURCE
CMAJ: Canadian Medical Association Journal;10/21/2008, Vol. 179 Issue 9, p892
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article underscores that young children still remain as primary victims of malaria. A report by the World Health Organization identified that about 247 million are estimated to have been infected with this disease, which continues to kill about 900,000 yearly, particularly children under five years of age. It also mentions that this disease remained endemic in 109 countries, including Africa in which only 3% of children in need have access to artemisinin-based combination therapy.
ACCESSION #
34680828

 

Related Articles

  • Malaria Fight Hinges on Drug First Used by Vietcong.  // Clinical Infectious Diseases;7/1/2008, Vol. 47 Issue 1, piii 

    The article reports on the international effort in treating and eradicating malaria. According to Jan Van Erps of the Roll Back Malaria Partnership program of the World Health Organization (WHO), therapies using artemisinin, a medicine developed by Chinese military experts during the 1970s and...

  • The global pipeline of new medicines for the control and elimination of malaria. Anthony, Melinda P; Burrows, Jeremy N; Duparc, Stephan; JMoehrle, Joerg; Wells, Timothy NC // Malaria Journal;2012, Vol. 11 Issue 1, p316 

    Abstract: Over the past decade, there has been a transformation in the portfolio of medicines to combat malaria. New fixed-dose artemisinin combination therapy is available, with four different types having received approval from Stringent Regulatory Authorities or the World Health Organization...

  • Multiple treatment comparisons in a series of anti-malarial trials with an ordinal primary outcome and repeated treatment evaluations. Whegang Youdom, Solange; Samson, Adeline; Basco, Leonardo K.; Thalabard, Jean-Christophe // Malaria Journal;2012, Vol. 11 Issue 1, p147 

    Background Artemisinin-based combination therapies (ACT) are widely used in African countries, including Cameroon. Between 2005 and 2007, five randomized studies comparing different treatment arms among artesunate-amodiaquine and other ACT were conducted in Cameroonian children aged two to 60...

  • High-level semi-synthetic production of the potent antimalarial artemisinin. Paddon, C. J.; Westfall, P. J.; Pitera, D. J.; Benjamin, K.; Fisher, K.; McPhee, D.; Leavell, M. D.; Tai, A.; Main, A.; Eng, D.; Polichuk, D. R.; Teoh, K. H.; Reed, D. W.; Treynor, T.; Lenihan, J.; Jiang, H.; Fleck, M.; Bajad, S.; Dang, G.; Dengrove, D. // Nature;4/25/2013, Vol. 496 Issue 7446, p528 

    In 2010 there were more than 200 million cases of malaria, and at least 655,000 deaths. The World Health Organization has recommended artemisinin-based combination therapies (ACTs) for the treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum. Artemisinin is a...

  • Control of malaria. Kar, Santwana; Kar, Santosh // Nature Reviews Drug Discovery;Jul2010, Vol. 9 Issue 7, p511 

    The article discusses various pharmacological approach in managing malaria in the U.S. It notes that the artemisinins in combination with a second drug has been recommended by the World Health Organization as the first-line treatment for uncomplicated Plasmodium (P.) falcifarum malaria. It also...

  • Artemisinin-based combination therapy for treatment of drug-resistant malaria. Dev, V.; Hojai, D. // Current Science (00113891);12/10/2009, Vol. 97 Issue 11, p1523 

    The article discusses the recommendation of the World Health Organization (WHO) regarding the use of combination therapies to combat the prevalence of drug-resistant Plasmodium falciparum malaria. It cites the artemisinin-based combination therapies which are offered for countries which...

  • Last line of defence. de Smet, Martin // New Scientist;6/20/2009, Vol. 202 Issue 2713, p22 

    In this article the author emphasizes the need to contain the emergence of drug-resistant malaria in Cambodia. He relates that there are reports from Cambodia of malaria developing resistance to artemisinins. Artemisinins are the best drugs to treat malaria, according to the article. He explains...

  • The Curative and Prophylactic Effects of Xylopic Acid on Plasmodium berghei Infection in Mice. Boampong, J. N.; Ameyaw, E. O.; Aboagye, B.; Asare, K.; Kyei, S.; Donfack, J. H.; Woode, E. // Journal of Parasitology Research;2013, p1 

    Efforts have been intensified to search for more effective antimalarial agents because of the observed failure of some artemisinin-based combination therapy (ACT) treatments of malaria in Ghana. Xylopic acid, a pure compound isolated from the fruits of the Xylopia aethiopica, was investigated to...

  • Positive manipulation? Creating the market for ACTs. Brieger, William // Africa Health;Nov2012, Vol. 35 Issue 1, p15 

    The article discusses the challenges in getting the right malaria treatment in Africa. It highlights the aim of the Affordable Medicines Facility for malaria (AMFm) to move consumption to artemisinin combination therapies (ACT) and to boost other products from the market. It mentions the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics